✦ LIBER ✦

Evaluation of the HER2/neu-derived peptide GP2 for use in a peptide-based breast cancer vaccine trial

✍ Scribed by Elizabeth A. Mittendorf; Catherine E. Storrer; Rebecca J. Foley; Katie Harris; Yusuf Jama; Craig D. Shriver; Sathibalan Ponniah; George E. Peoples

Publisher: John Wiley and Sons
Year: 2006
Tongue: English
Weight: 281 KB
Volume: 106
Category: Article
ISSN: 0008-543X
DOI: 10.1002/cncr.21849

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Results of the first phase 1 clinical tr

Results of the first phase 1 clinical trial of the HER-2/neu peptide (GP2) vaccine in disease-free breast cancer patients : United States Military Cancer Institute Clinical Trials Group Study I-04

✍ Mark G. Carmichael; Linda C. Benavides; Jarrod P. Holmes; Jeremy D. Gates; Eliza 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 424 KB 👁 1 views